This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Centre National De La Recherche Scientifique. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Odile Thoison: Innovator in Cancer Treatment
Introduction
Odile Thoison is a notable inventor based in Palaiseau, France. She has made significant contributions to the field of cancer treatment through her innovative research and development of new compounds. Her work is recognized for its potential impact on medical science and patient care.
Latest Patents
Odile Thoison holds a patent for N-substituted 3,4-bis (catechol) pyrrole compounds, which are designed for use in the treatment of cancer. The patent describes a compound of formula (I) with specific structural characteristics, including various integers and electro-attractive groups. This invention aims to provide effective therapeutic options for cancer patients, showcasing her commitment to advancing medical research.
Career Highlights
Odile Thoison is affiliated with the Centre National de la Recherche Scientifique, where she conducts her research. Her career is marked by a dedication to exploring innovative solutions in the field of oncology. She has demonstrated a strong ability to translate complex scientific concepts into practical applications.
Collaborations
Throughout her career, Odile has collaborated with esteemed colleagues, including Joanna Bakala and Bernard Delpech. These partnerships have enriched her research and contributed to the development of her patented compounds.
Conclusion
Odile Thoison's work exemplifies the spirit of innovation in the medical field, particularly in cancer treatment. Her contributions through patents and collaborations highlight her role as a leading inventor in this critical area of research.